HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

3rd Edition of

International Ophthalmology Conference

March 10-12, 2025 | Rome, Italy

IOC 2025

The effectiveness of surgical treatment of terson syndrome

Speaker at International Ophthalmology Conference 2025 - Anna Rusanovskaia
State Budgetary Healthcare Institution , Russian Federation
Title : The effectiveness of surgical treatment of terson syndrome

Abstract:

Terson's syndrome (hemorrhagic oculocerebral syndrome) is a vitreal, preretinal, subgialoid or subretinal hemorrhage associated with acute subarachnoid, intracerebral hemorrhage, or traumatic brain injury. The clinical picture is characterized by a sharp mono or bilateral loss of vision in the background of intracranial hemorrhage. The main method of treatment is timely vitrectomy.  According to the literature, this type of surgical treatment is effective in 81% of cases. Terson syndrome is a serious complication of intracranial hemorrhage, leading to a significant reduction in vision and disability of patients. However, with timely and reasonable surgical treatment, a complete restoration of visual functions is possible, because Terson's syndrome is rarely accompanied by ischemic angioretinopathy.
A case report: A 42-year-old woman was taken to the intensive care unit in a coma. The diagnosis was established: subarachnoid hemorrhage, rupture of the giant aneurysm of the right carotid artery. Surgical treatment was performed: osteoplastic craniotomy in the right fronto-temporal-parietal region, clipping of the aneurysm of the right carotid artery. On return of consciousness, the patient was diagnosed with reduced vision to correct light projection of both eyes. After stabilization of the physical condition, 25-gauge vitrectomy was performed on both eyes. During vitrectomy, a dense adhesion of the posterior hyaloid membrane to the retina, vitreal and subhaloid hemorrhage (at the stage of fibrosis) were detected . Best-corrected visual acuity (BCVA) with Snellen was 20/25 on the first day after surgery, and the BCVA was 20/20 in both eyes in one year and in two years after surgical treatment. Fields of vision were in the normal range. Spectral domain optical coherence tomography (OCT) of the macular region and optic nerves were within normal limits. There were no signs of optic atrophy.

Biography:

Dr. A. Rusanovskaya graduated from Medical University in 2006 and completed her PhD at 33 from S.N. Fedorov NMTC "MNTK" Eye Microsurgery in Russia, focusing on vitreoretinal surgery and early macular pathology treatment. Since 2015, she has worked at City Clinical Hospital #52 in Moscow. Dr. Rusanovskaya is the author or co-author of over 20 publications in renowned journals and has participated in more than 30 national and international congresses. She is also a co-author of two Russian Federation patents. Her main research areas include retinal diseases such as diabetic retinopathy, age-related macular degeneration, and vitreoretinal surgery.

Watsapp